Precision in BPH Care: Choosing the Ideal Alpha-Blocker

Alfoo logo
Current recommendations for the pharmacological management of BPH include alpha-blockers, 5-ARIs, and phosphodiesterase-5 inhibitors, either alone or in combination.

Current recommendations for the pharmacological management of BPH include alpha-blockers, 5-ARIs, and phosphodiesterase-5 inhibitors, either alone or in combination.1

Adverse sexual side effects may arise from the drug class as a whole or specific medications within these classes.

Adverse sexual side effects may arise from the drug class as a whole or specific medications within these classes.1,2

α - adrenoceptor blockers
5α-reductase inhibitors
Phosphodiesterase-5 inhibitors
Discussing the risks and side effects of BPH pharmacologic therapy is essential to help patients make informed decisions that align with their personal health goals.

Discussing the risks and side effects of BPH pharmacologic therapy is essential to help patients make informed decisions that align with their personal health goals.2

Alpha-blockers are the first-line medical option in the management of BPH.

Alpha-blockers are the first-line medical option in the management of BPH.1,2

Among, alpha-blockers, alfuzosin stands out with good efficacy along with fewer sexual side effects than other alpha-blockers in sexually active males.

Among, alpha-blockers, alfuzosin stands out with good efficacy along with fewer sexual side effects than other alpha-blockers in sexually active males.1,2

Sexual AEs associated with alpha-blockers
Alfoo logo

Alfoo-Improved Pharmacokinetics

ALFOO, containing  Alfuzosin molecule, is Anti-BPH which helps in treatment of LUTS due to BPH in Young Sexually Active Male in 40-60 year old age group

Alfoo banner